+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Clinical Biomarker Testing Market Analysis, 2020

  • PDF Icon

    Report

  • 178 Pages
  • July 2020
  • Region: Global
  • MarkNtel Advisors LLP
  • ID: 5447754

Government Aid in Different Countries Helping in Promulgation of Clinical Biomarker Testing Market

Global Clinical Biomarker Testing Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Clinical Biomarker Testing market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The growing aging population coupled with rising rates of obesity are the major factors for the growth of biomarker testing. Other factors include emerging number of cancer therapies, advancement of bioinformatics. These reasons are expected to further drive the growth of clinical biomarker testing growth during 2020-25. According to this research report titled “Global Clinical Biomarker Testing Market Analysis, 2020”, the Global Clinical Biomarker Testing market is anticipated to grow at a substantial CAGR during 2020-25. However, the high cost of cancer biomarker testing is currently restraining the market growth.

Cancer Immunotherapy Segment Acquired a Prominent Market Share

The cancer immunotherapy segment growth is constantly escalating owing to the rising prevalence of pancreas cancer, stomach cancer, breast cancer, collateral cancer, and prostate cancer. Advancement of diagnosing techniques such as transcriptomic, genomics, proteomics and metabolomics is expected to propel the growth of biomarker testing market during 2020-25. Rising awareness in healthcare professionals for an early diagnosing procedure and a rise in government funding for treatment of different diseases are expected to bolster the demand for clinical biomarker testing during the forecast period as stated in the research report “Global Clinical Biomarker Testing Market Analysis, 2020”.

Europe and North America Gained a Substantial Market Share

The demand for personalized medicines is bolstering in the European and American region, therefore, driving the Clinical Biomarker Testing market. Furthermore, emerging need for toxicology technologies, extensive R&D activities is driving the demand for clinical biomarker testing in Europe and North America. Therefore, Europe and North America held a maximum share in 2019. However, the Asia-Pacific region has immense growth potential due to increasing number of clinical laboratories in countries such as India and China.

According to the publisher, Abbott Laboratories, Adaptive Biotechnologies, Becton Dickinson, Bio-Rad Laboratories, Agilent Technologies, Hologic, Merck and Co., Thermofisher Scientific, Danaher Corporation, AbbVie Inc. are few of the leading players in the Global Clinical Biomarker Testing Market.

Key Questions Answered in the Market Research Report


1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Clinical Biomarker Testing Market?
2. What are the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Clinical Biomarker Testing Market?
4. Who are the key competitors or market players and how they perform in Global Clinical Biomarker Testing Market on the basis of competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Global Clinical Biomarker Testing Market study?

Table of Contents

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation
2. Executive Summary3. Expert Verbatim- Interview Excerpts of 10 industry experts
4. Global Clinical Biomarker Testing Market Outlook, 2015-2025F
4.1. Market Size & Analysis
4.1.1. By Revenues
4.2. Market Share & Analysis
4.2.1. By Type
4.2.1.1. Cancer
4.2.1.2. Metabolism
4.2.1.3. Infectious Disease
4.2.1.4. Cardiology
4.2.1.5. Neurology
4.2.1.6. Immunological Disease
4.2.2. By Application
4.2.2.1. Drug discovery
4.2.2.2. Nutrigenomics
4.2.2.3. Toxicology Testing
4.2.2.4. Personalized medicine
4.2.2.5. Functional Genomics
4.2.3. By End-User
4.2.3.1. Pharma and Biotech Companies
4.2.3.2. Diagnostic Tool Companies
4.2.3.3. Healthcare IT/Big Data Companies
4.2.3.4. Clinical Laboratories
4.2.3.5. Research Institutes
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. South America
4.2.4.3. Europe
4.2.4.4. Asia-Pacific
4.2.4.5. Middle East & Africa
4.2.5. By Company
4.2.5.1. Revenue Shares
4.2.5.2. Strategic Factorial Indexing
4.2.5.3. Competitor Placement in MarkNtel Quadrant
5. North America Clinical Biomarker Testing Market Outlook, 2015-2025F
5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Type
5.2.2. By Application
5.2.3. By End-User
5.2.4. By Country
5.2.4.1. US
5.2.4.2. Canada
5.2.4.3. Mexico
5.3. US Clinical Biomarker Testing Market Outlook, 2015-2025F
5.3.1. Market Size & Analysis
5.3.1.1. By Revenues
5.4. Canada Clinical Biomarker Testing Market Outlook, 2015-2025F
5.4.1. Market Size & Analysis
5.4.1.1. By Revenues
5.5. Mexico Clinical Biomarker Testing Market Outlook, 2015-2025F
5.5.1. Market Size & Analysis
5.5.1.1. By Revenues
6. South America Clinical Biomarker Testing Market Outlook, 2015-2025F
6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Type
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. Brazil
6.2.4.2. Argentina
6.2.4.3. Others
6.3. Brazil Clinical Biomarker Testing Market Outlook, 2015-2025F
6.3.1. Market Size & Analysis
6.3.1.1. By Revenues
6.4. Argentina Clinical Biomarker Testing Market Outlook, 2015-2025F
6.4.1. Market Size & Analysis
6.4.1.1. By Revenues
7. Europe Clinical Biomarker Testing Market Outlook, 2015-2025F
7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Type
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. The UK
7.2.4.2. Germany
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Spain
7.2.4.6. Others
7.3. UK Clinical Biomarker Testing Market Outlook, 2015-2025F
7.3.1. Market Size & Analysis
7.3.1.1. By Revenues
7.4. Germany Clinical Biomarker Testing Market Outlook, 2015-2025F
7.4.1. Market Size & Analysis
7.4.1.1. By Revenues
7.5. France Clinical Biomarker Testing Market Outlook, 2015-2025F
7.5.1. Market Size & Analysis
7.5.1.1. By Revenues
7.6. Italy Clinical Biomarker Testing Market Outlook, 2015-2025F
7.6.1. Market Size & Analysis
7.6.1.1. By Revenues
7.7. Spain Clinical Biomarker Testing Market Outlook, 2015-2025F
7.7.1. Market Size & Analysis
7.7.1.1. By Revenues
8. Asia-Pacific Clinical Biomarker Testing Market Outlook, 2015-2025F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. South Korea
8.2.4.6. Others
8.3. China Clinical Biomarker Testing Market Outlook, 2015-2025F
8.3.1. Market Size & Analysis
8.3.1.1. By Revenues
8.4. India Clinical Biomarker Testing Market Outlook, 2015-2025F
8.4.1. Market Size & Analysis
8.4.1.1. By Revenues
8.5. Japan Clinical Biomarker Testing Market Outlook, 2015-2025F
8.5.1. Market Size & Analysis
8.5.1.1. By Revenues
8.6. Australia Clinical Biomarker Testing Market Outlook, 2015-2025F
8.6.1. Market Size & Analysis
8.6.1.1. By Revenues
8.7. South Korea Clinical Biomarker Testing Market Outlook, 2015-2025F
8.7.1. Market Size & Analysis
8.7.1.1. By Revenues
9. Middle East and Africa Clinical Biomarker Testing Market Outlook, 2015-2025F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Type
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. UAE
9.2.4.2. Saudi Arabia
9.2.4.3. Others
9.3. UAE Clinical Biomarker Testing Market Outlook, 2015-2025F
9.3.1. Market Size & Analysis
9.3.1.1. By Revenues
9.4. Saudi Arabia Clinical Biomarker Testing Market Outlook, 2015-2025F
9.4.1. Market Size & Analysis
9.4.1.1. By Revenues
10. Global Clinical Biomarker Testing Dynamics
10.1. Drivers
10.2. Challenges
10.3. Impact Analysis
11. Global Clinical Biomarker Testing Regulations, Product Standards12. Global Clinical Biomarker Testing Value Chain Analysis13. Global Clinical Biomarker Testing Intellectual Property Rights Analysis14. Global Clinical Biomarker Testing Hotspots & Opportunities
15. Competition Outlook
15.1. Competitor Wise Growth Strategies
15.1.1. Product Portfolio
15.1.2. Brand Specialization
15.1.3. Target Markets
15.1.4. Research & Development
15.1.5. Strategic Alliances & Initiatives
15.2. Company Profiles
15.2.1. Abbott Laboratories
15.2.2. Adaptive Biotechnologies
15.2.3. Becton Dickinson
15.2.4. Bio-Rad Laboratories
15.2.5. Agilent Technologies
15.2.6. Hologic
15.2.7. Merck and Co.
15.2.8. Thermofisher Scientiifc
15.2.9. Danaher Corporation
15.2.10. AbbVie Inc.
16. Disclaimer

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Hologic
  • Merck and Co.
  • Thermofisher Scientific
  • Danaher Corporation
  • AbbVie Inc.

Methodology

Loading
LOADING...